LIMN
Financials
- Market Capitalization 5.68 M
- Employee 1
- Founded 2020
- CEO N/A
- Website liminatuspharma.com
- Headquarter Delaware, United States
- FIGI BBG01HVYG111
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4894 |  PCSA Processa Pharmaceuticals, Inc. - Common Stock | 2.06 USD | -3.29% | -2.37% | +7.85% | -7.41% | 5.75 M USD | ||
| 4898 |  BGMS Bio Green Med Solution, Inc. - Common Stock | 0.86 USD | -3.37% | -2.27% | -1.15% | -85.67% | 5.70 M USD | ||
| 4901 |  BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.18 USD | -75.00% | -77.50% | -77.22% | -88.61% | 5.63 M USD | ||
| 4909 |  PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.52 USD | -3.70% | -1.89% | -11.86% | -48.00% | 5.58 M USD |
Frequently asked questions about Liminatus Pharma, Inc. Class A Common Stock
What is the Liminatus Pharma, Inc. Class A Common Stock stock price today?
The current price of Liminatus Pharma, Inc. Class A Common Stock (LIMN) is 4.23. Over the past 24 hours, the stock has changed by -3.86%. Follow the LIMN chart for real-time price dynamics.
What is the stock ticker of Liminatus Pharma, Inc. Class A Common Stock?
Liminatus Pharma, Inc. Class A Common Stock trades under the ticker LIMN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Liminatus Pharma, Inc. Class A Common Stock stock going up?
LIMN has changed by -16.07% over the last week, +3745.45% over the last month, and +43.39% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Liminatus Pharma, Inc. Class A Common Stock?
Liminatus Pharma, Inc. Class A Common Stock currently has a market capitalization of 5.68 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Liminatus Pharma, Inc. Class A Common Stock earnings last quarter?
Last quarter, Liminatus Pharma, Inc. Class A Common Stock reported earnings of -1.5 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Liminatus Pharma, Inc. Class A Common Stock net income for the last quarter?
Liminatus Pharma, Inc. Class A Common Stock reported net income of -1.41 M for the last quarter. The previous quarter showed -1.12 M, which means net income changed by -25.23%.
How many employees does Liminatus Pharma, Inc. Class A Common Stock have?
As of the latest available data, Liminatus Pharma, Inc. Class A Common Stock has 1 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Liminatus Pharma, Inc. Class A Common Stock stock?
You can buy Liminatus Pharma, Inc. Class A Common Stock (LIMN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Liminatus Pharma, Inc. Class A Common Stock stock?
Investing in Liminatus Pharma, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LIMN chart and related analysis on metatrader.com as part of your research.